ThermoGenesis

$2.56
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.

-$0.35 (-11.51%) Today

-$0.13 (-4.83%) As of 11:14 AM UTC after-hours

Why Robinhood?

You can buy or sell ThermoGenesis and other stocks, options, and ETFs commission-free!

About THMO

ThermoGenesis Holdings, Inc. engages in the research, development, commercialization, and marketing of automated cell processing technologies for the cell and gene therapy field. It operates through the Device and Clinical Development segment. The Device segment includes the development and commercialization of automated technologies for cell-based therapeutics and bioprocessing. The Clinical Development segment utilizes autologous stem cell-based therpeutics. The company was founded by Philip H. Coelho in 1986 and is headquartered in Rancho Cordova, CA. The listed name for THMO is ThermoGenesis Holdings, Inc. Common Stock.

CEO

Xiao Chun Xu

Employees

Headquarters

Rancho Cordova, California

Founded

1986

Market Cap

19.32M

Price-Earnings Ratio

—

Dividend Yield

—

Average Volume

2.97M

High Today

$3.03

Low Today

$2.62

Open Price

$2.84

Volume

2.12M

52 Week High

$14.18

52 Week Low

$1.63

Collections

Technology

Health

Medical

Advertising and Marketing

THMO Earnings

-$1.36

-$0.89

-$0.42

$0.05

Q2 FY19

Q3 FY19

Q4 FY19

Q1 FY20

Q2 FY20

Q3 FY20

Q4 FY20

Estimated

— per share

Actual

Expected Mar 23, After Hours